Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Assets (2016 - 2025)

Historic Return on Assets for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to 0.17%.

  • United Therapeutics' Return on Assets rose 100.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.16% for FY2024, which is 200.0% up from last year.
  • Latest data reveals that United Therapeutics reported Return on Assets of 0.17% as of Q3 2025, which was up 100.0% from 0.16% recorded in Q2 2025.
  • In the past 5 years, United Therapeutics' Return on Assets registered a high of 0.17% during Q3 2025, and its lowest value of 0.09% during Q1 2021.
  • In the last 5 years, United Therapeutics' Return on Assets had a median value of 0.13% in 2023 and averaged 0.13%.
  • As far as peak fluctuations go, United Therapeutics' Return on Assets plummeted by -500bps in 2021, and later soared by 400bps in 2022.
  • Quarter analysis of 5 years shows United Therapeutics' Return on Assets stood at 0.09% in 2021, then soared by 32bps to 0.12% in 2022, then increased by 13bps to 0.14% in 2023, then increased by 19bps to 0.16% in 2024, then increased by 1bps to 0.17% in 2025.
  • Its Return on Assets was 0.17% in Q3 2025, compared to 0.16% in Q2 2025 and 0.16% in Q1 2025.